Compare · MEHA vs MTCR

MEHA vs MTCR

Side-by-side comparison of Functional Brands Inc. (MEHA) and Metacrine Inc. (MTCR): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both MEHA and MTCR operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • MTCR has more recent analyst coverage (4 ratings vs 0 for MEHA).
MetricMEHAMTCR
Company
Functional Brands Inc.
Metacrine Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2020
News (4w)
0
0
Recent ratings
0
4
MTCR

Metacrine Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with liver and gastrointestinal diseases. It is developing MET409 that has completed Phase 1b proof-of-concept clinical trial for the treatment of patients with non-alcoholic steatohepatitis (NASH); and is in Phase 2a clinical trial in combination with empagliflozin for the treatment of patients with type 2 diabetes mellitus and NASH. The company also develops MET642, which is in Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis patients. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Latest MEHA

Latest MTCR